Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of COVID-19 Vaccines in Chronic Liver Disease
NCT05017805Unknown
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Aug 2021
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoints: Safety of coronavirus vaccine at 2 months and Immunogenicity of coronavirus vaccine at 2 months. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05017805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05017805.